BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 32735885)

  • 1. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
    Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
    Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
    J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
    Sun HB; Zhang YM; Huang LG; Lai QN; Mo Q; Ye XZ; Wang T; Zhu ZZ; Lv XL; Luo YJ; Gao SD; Xu JS; Zhu HH; Li T; Wang ZK
    PLoS One; 2020; 15(9):e0239532. PubMed ID: 32976531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
    Bao J; Li C; Zhang K; Kang H; Chen W; Gu B
    Clin Chim Acta; 2020 Oct; 509():180-194. PubMed ID: 32511971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
    Wan S; Yi Q; Fan S; Lv J; Zhang X; Guo L; Lang C; Xiao Q; Xiao K; Yi Z; Qiang M; Xiang J; Zhang B; Chen Y; Gao C
    Br J Haematol; 2020 May; 189(3):428-437. PubMed ID: 32297671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.
    Li H; Chen K; Liu M; Xu H; Xu Q
    J Infect; 2020 Jul; 81(1):115-120. PubMed ID: 32325129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    Jiang M; Guo Y; Luo Q; Huang Z; Zhao R; Liu S; Le A; Li J; Wan L
    J Infect Dis; 2020 Jun; 222(2):198-202. PubMed ID: 32379887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of CD8 marker on T-cells in COVID-19 patients.
    Ganji A; Farahani I; Khansarinejad B; Ghazavi A; Mosayebi G
    Blood Cells Mol Dis; 2020 Jul; 83():102437. PubMed ID: 32325421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
    Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
    J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.